CLINICAL_TRIALS
trial_result
· 2016-05-18
Clinical Trial Update: Long-term Extension Trial of Asenapine in Subjects With Schizophrenia (Study P06125) [Phase 3]
Summary
Long-term extension Phase III trial of asenapine in schizophrenia completed; results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Organon and Co | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2016-05-18